GlaxoSmithKline Plc is likely to raise stake in its Indian arm to 51 per cent through a buyback plan. At present, the Indian arm, GlaxoSmithKline Consumer Healthcare is an associate company of the......
GlaxoSmithKline Consumer Healthcare on Tuesday said the multi-billion dollar global deal between parent GlaxoSmithKline Plc and Swiss drug major Novartis won't affect its business in India. The two......
Capital market watchdog Sebi on Tuesday slapped a fine of Rs 25 lakh (Rs 2.5 million) on Glaxo Group Ltd, a promoter entity of drug maker Glaxo Smithkline Pharmaceuticals, for failing to make......
The government on Thursday cleared Rs 6,400-crore (Rs 64-billion) FDI proposal of global healthcare company GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. The Cabinet......
FIPB on Monday cleared Rs 6,400-crore (Rs 64-billion) foreign direct investment proposal of GlaxoSmithKline to acquire additional 24.33 per cent stake in its India arm. "The proposal of......